Active Ingredient(s):Lubiprostone FDA Approved: * January 31, 2006 Pharm Company: *SUCAMPO PHARMS Category:Irritable Bowel Syndrome
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company.
The drug was developed by Sucampo Pharmaceuticals and approved by the Food and Drug Administration (FDA) in 2006.[3...
* May have multiple approval dates, manufacturers, or labelers. 5 Discussions